The invention provides compounds of Formula (I):
1
wherein: R
1
-R
5
, A, L, and X have any of the values defined in the specification that are CCR-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use, and methods and intermediates useful for preparing them.
[EN] CCR-3 RECEPTOR ANTAGONISTS VII<br/>[FR] ANTAGONISTES VII DU RECEPTEUR CCR3
申请人:HOFFMANN LA ROCHE
公开号:WO2003045917A2
公开(公告)日:2003-06-05
The present invention relates to compounds of Formula (1) wherein R1 R4, A, D, and L are as defined in the specification. The compounds are useful as CCR-3 receptor antagonists, and therefore, may be used for treatment of CCR-3 mediated diseases.